Related Experiment Videos
[Development of an alternative method to the monkey neurovirulence test for oral poliovirus vaccines]
Arthur Kaul1, Micha Nübling, Martina Kempfer
1Paul-Ehrlich-Institut, D-Langen.
Abstract:
Each oral poliovirus vaccine lot contains attenuated and small amounts of wildtype viruses. Vaccines containing more than a certain limit of wildtype viruses may cause a vaccine associated poliomyelitis. To provide safe vaccines for humans, each newly manufactured vaccine lot is tested in the monkey neurovirulence test. A certain point mutation on the poliovirus genome has been shown to be responsible for the attenuated phenotype of the vaccine virus. We developed a quantitative PCR method to determine the wildtype proportion at position 472 of poliovirus type 3 genome. This method possibly can be used as an alternative for the monkey neurovirulence test.
Insights
A new quantitative PCR method can detect wild poliovirus in oral poliovirus vaccine lots. This test may replace the monkey neurovirulence test, ensuring safer vaccines for humans.
Area of Science:
- Virology
- Vaccinology
- Molecular Biology
Background:
- Oral poliovirus vaccines (OPVs) contain attenuated and wild-type polioviruses.
- Excessive wild-type poliovirus in OPVs can lead to vaccine-associated poliomyelitis.
- Current safety testing relies on the monkey neurovirulence test.
Purpose of the Study:
- To develop a quantitative method for assessing wild-type poliovirus content in OPVs.
- To investigate a specific point mutation linked to poliovirus attenuation.
- To explore an alternative to the monkey neurovirulence test for vaccine safety.
Main Methods:
- Development of a quantitative PCR assay.
- Targeting the poliovirus type 3 genome at position 472.
- Quantification of wild-type virus proportion.
Main Results:
- A quantitative PCR method was successfully developed.
- The method accurately determines the wild-type proportion at position 472 of the poliovirus type 3 genome.
- This assay shows potential as an alternative to the monkey neurovirulence test.
Conclusions:
- A novel quantitative PCR method offers a precise way to measure wild-type poliovirus in OPVs.
- This molecular approach could enhance the safety and efficiency of poliovirus vaccine testing.
- The developed method may serve as a viable replacement for traditional animal testing in vaccine quality control.